Overview

Fasting on Newly Diagnosed Breast Cancer

Status:
Terminated
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
This study is to see how safe the use of short-term fasting is in breast cancer patients who will receive chemotherapy before undergoing surgery and to examine if the use of short-term fasting will decrease the side effects of chemotherapy and how much a tumor shrinks while receiving chemotherapy.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Western Regional Medical Center
Treatments:
Albumin-Bound Paclitaxel
Cyclophosphamide
Docetaxel
Doxorubicin
Liposomal doxorubicin
Paclitaxel
Pertuzumab
Trastuzumab